Release Date: 17/11/11 14:24 Summary: Presentation to the Annual General Meeting Price Sensitive: No Download Document 6.41MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%